Recent news on Cefdinir

Lupin Pharmaceuticals, Inc. Announces Final FDA Approval of ...  -  May 9, 2007
PipelineReview.com (press release),Lupin's Cefdinir capsules and suspensions are the AB-rated generic equivalent of Abbott Laboratories' Omnicef(R) which had US sales of approximately $787

Lupin gets USFDA nod for Cefdinir  -  May 8, 2007
Economic Times,MUMBAI: Pharmaceutical company Lupin has received US Food and Drug Administration (FDA) approval for its antibiotic drug Cefdinir for oral suspension.

India's Lupin gets US FDA approval for Cefdinir oral suspension drug  -  May 9, 2007
Forbes,Lupins's Cefdinir is the generic equivalent of Abbott Laboratories (nyse: ABT - news - people ) Omnicef, and is designed for the treatment of patients with

Lupin Q4 net rises 173% to Rs137 crore  -  May 9, 2007
Livemint,Lupin also announced that it received approval from the US Food and Drug Administration to market its antibiotic drug cefdinir in the US.

Paving the path for Lupin  -  May 6, 2007
Daily News & Analysis,Lupin has received approval only for 300 mg Cefdinir capsules. “So far, the federal judge has been in Lupin’s favour,� said a source close to the company.

Medicis Begins Shipping PERLANE to Physicians  -  May 21, 2007
Primenewswire (press release),PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur),

Abbott, partner sue to block regulatory OK of generic drug  -  Mar 31, 2007
Chicago Tribune,Abbott and Tokyo-based partner Astellas Pharma Inc. said the competing medicines would infringe an Astellas patent on a crystalline form of cefdinir,

Morgan Stanley overweight on Lupin  -  Feb 23, 2007
Moneycontrol.com,The company specializes in cephalosporins (including ceftriaxone, cefixime and, likely cefdinir in 2007), and prils family (including lisinopril,

Medicis to Present At Roth Capital Partners 19th Annual OC Conference  -  Feb 15, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R)

Research Calls: India Cements  -  Jan 28, 2007
Business Standard,While the sales in the past quarter were driven mainly by the rise of 105 per cent in the sales of suprax, the launch of generic cefdinir capsules,

Medicis to Present At JPMorgan 25th Annual Healthcare Conference  -  Jan 4, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R)

Hold Lupin: Kotak Securities  -  Dec 25, 2006
Moneycontrol.com,We believe that existing products basket will continue to perform stably and generic Cefdinir would be big growth driver in FY08E.

Hold Lupin: Kotak Securities  -  26 Dec 2006
Moneycontrol.com,We believe that existing products basket will continue to perform stably and generic Cefdinir would be big growth driver in FY08E.

Patheon limps in with end of year results  -  Dec 25, 2006
OutSourcing-Pharma.com,...after receiving a warning letter from the FDA in September 2005 regarding its production of Abbott's oral antibiotic, Omnicef (cefdinir).

Medicis Declares Cash Dividend  -  Dec 14, 2006
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R)

Hopeful for Cefdinir launch after May '07: Lupin Labs  Oct 19, 2006
He adds that for Cefdinir they have an approval for both capsule and dry syrup and the patent is coming off in May 07 and that’s when the launch is expected. ... -Moneycontrol.com, Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of ...  Nov 7, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone (press release), Medicis to Present at UBS Global Life Sciences Conference  Sep 22, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Medicis to Present at Credit Suisse Healthcare Conference  -  Nov 13, 2006
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R)

India top drug tweaker again  Aug 16, 2006
Aurobindo filed for cefepime and cefdinir whereas Orchid Chemicals filed for cefdinir. The patents of both Omnicef ($650 million ... -Daily News & Analysis

Medicis Announces Second Quarter 2006 Conference Call and Webcast  Jul 31, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Immtech Appoints Carol Ann Olson, MD to Senior Vice President of ...  Jul 25, 2006
...responsible for clinical development of antibiotics for outpatient respiratory tract infections, including clarithromycin (Biaxin(R)) and cefdinir (Omnicef(R ... -PR Newswire

Medicis Names Jason Hanson Executive Vice President and General ...  Jul 12, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Euronext Paris) - Ipsen : Medicis and Ipsen decide to focus ...  Jul 12, 2006
The Company's products include the prescription brands RESTYLANE®, DYNACIN® (minocycline HCl), LOPROX® (ciclopirox), OMNICEF® (cefdinir), PLEXION® (sodium ... -Euronext (persbericht)



Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP ...  May 8, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - PharmaLive.com





(PZ) Medicis to Ring the Opening Bell of the NYSE  Mar 20, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Houston Chronicle

Strep throat grows stronger  Feb 3, 2006
...antibiotics such as cephalexin, and only 7 percent of children receiving newer generation cephalosporins, such as cefpodoxime and cefdinir, return to the doctor ... - Quad City Times,

Medicis to Present at Merrill Lynch 17th Annual Global ...  Feb 3, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Genetic Engineering News

Strep throat grows stronger  Feb 3, 2006
...antibiotics such as cephalexin, and only 7 percent of children receiving newer generation cephalosporins, such as cefpodoxime and cefdinir, return to the doctor ... - Quad City Times

An open letter to the pharmaceutical industry  Jan 29, 2006
But now nobody makes it, so we usually use cefdinir for those patients.It works just as well, but since it is new and fancy, costs more than cefixime. ... - Staunton News Leader

Abbott shares rise on Q4 and Guidant win  Jan 26, 2006
...during the period was also supported by: the cholesterol-buster TriCor (fenofibrate), up 37.5% to $312 million; the antibiotic Omnicef (cefdinir), rising 27.5 ... - Pharma Times (subscription)

Kids tee off  Jan 10, 2006
...antibiotics such as cephalexin, and only 7 percent of children receiving newer-generation cephalosporins, such as cefpodoxime and cefdinir, return to the doctor ... - Indianapolis Star

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional